| Literature DB >> 32581361 |
Craig J Anderson1, Frances Connor2, Sarah J Aitken2,3,4, Oriol Pich5, Vasavi Sundaram2,6, Christine Feig2, Tim F Rayner2, Margus Lukk2, Stuart Aitken1, Juliet Luft1, Elissavet Kentepozidou6, Claudia Arnedo-Pac5, Sjoerd V Beentjes7, Susan E Davies4, Ruben M Drews2, Ailith Ewing1, Vera B Kaiser1, Ava Khamseh1,8, Erika López-Arribillaga5, Aisling M Redmond2, Javier Santoyo-Lopez9, Inés Sentís5, Lana Talmane1, Andrew D Yates6, Colin A Semple1, Núria López-Bigas5,10,11, Paul Flicek2,6, Duncan T Odom12,13, Martin S Taylor14.
Abstract
Cancers arise through the acquisition of oncogenic mutations and grow by clonal expansion1,2. Here we reveal that most mutagenic DNA lesions are not resolved into a mutated DNA base pair within a single cell cycle. Instead, DNA lesions segregate, unrepaired, into daughter cells for multiple cell generations, resulting in the chromosome-scale phasing of subsequent mutations. We characterize this process in mutagen-induced mouse liver tumours and show that DNA replication across persisting lesions can produce multiple alternative alleles in successive cell divisions, thereby generating both multiallelic and combinatorial genetic diversity. The phasing of lesions enables accurate measurement of strand-biased repair processes, quantification of oncogenic selection and fine mapping of sister-chromatid-exchange events. Finally, we demonstrate that lesion segregation is a unifying property of exogenous mutagens, including UV light and chemotherapy agents in human cells and tumours, which has profound implications for the evolution and adaptation of cancer genomes.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32581361 PMCID: PMC7116693 DOI: 10.1038/s41586-020-2435-1
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962